Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 3,571 shares at $798.00 ($2.8M) on 2023-02-06, disclosed to the SEC on 2023-02-08.
Open-market sale of $2.8M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $797.00 | 500 | $399K | 14.0% |
| 2 | $798.00 | 3,071 | $2.5M | 86.0% |
| Total | $797.86 avg | 3,571 | $2.8M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-01-30 | $747 | — | Filing → |